Liraglutide (Saxenda / Victoza) vs Tirzepatide (Mounjaro / Zepbound)
Both are used for lose fat. Here's how they compare on human evidence, mechanism, safety and availability — in plain English.
| Liraglutide (Saxenda / Victoza) | Tirzepatide (Mounjaro / Zepbound) | |
|---|---|---|
| Human evidence | ★★★★☆ | ★★★★★ |
| Legal status | Prescription | Prescription |
| How it works | Daily short-acting GLP1R agonist — the first-generation version of semaglutide's mechanism. | Dual agonist of GIPR (GIP receptor) and GLP1R. GIP receptor activation in the hypothalamus and adipose tissue synergises with GLP-1, producing greater appetite suppression and fat loss than GLP-1 alone. |
| In plain English | The older, daily-injection GLP-1. Works, but weaker than weekly semaglutide and needs a daily shot. | Hits two "I'm full" gut-hormone switches at once instead of one — so it works even better. SURMOUNT-1: 22.5% bodyweight lost, approaching bariatric-surgery territory. |
| Bottom line | Largely superseded by weekly agents. | Currently the most effective approved obesity drug. |
| Availability | Prescription only | Prescription only |
Which is better for lose fat?
Tirzepatide (Mounjaro / Zepbound) has the stronger human-evidence rating (★★★★★ vs ★★★★☆), but the right choice still depends on your goal, tolerance and budget.
Full breakdowns: Liraglutide (Saxenda / Victoza) · Tirzepatide (Mounjaro / Zepbound).
Common questions
Is Liraglutide (Saxenda / Victoza) or Tirzepatide (Mounjaro / Zepbound) better for lose fat?
Tirzepatide (Mounjaro / Zepbound) has the stronger human-evidence rating (★★★★★ vs ★★★★☆), but the right choice still depends on your goal, tolerance and budget.
What's the difference between Liraglutide (Saxenda / Victoza) and Tirzepatide (Mounjaro / Zepbound)?
Liraglutide (Saxenda / Victoza): Largely superseded by weekly agents. — Tirzepatide (Mounjaro / Zepbound): Currently the most effective approved obesity drug.